Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Olaf Eickmeier

3PUBLICATIONS

3CO-AUTHORS

Pacific Peoples theory of change models for healthAllergyStructural properties of condensed matter

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (3)

Sort by Publication Date:

|Feb 13, 2026

Relating Improvement in Gastrointestinal (CFAbd-Score<sup>©</sup>) and Sinonasal (SNOT) Symptoms During Therapy With Elexacaftor/Tezacaftor/Ivacaftor in CF Patients.

Jochen G Mainz, Vivien Greiner, Pauline Sadrieh

|Dec 31, 2019

Clinical relevance of Aspergillus fumigatus sensitization in cystic fibrosis.

Olaf Eickmeier, Ulrich M Zissler, Julia Wittschorek

|Feb 04, 2017

Pro-resolving lipid mediator Resolvin D1 serves as a marker of lung disease in cystic fibrosis.

Olaf Eickmeier, Daniela Fussbroich, Klaus Mueller

Pageof 1

Frequent Collaborators

1 joint publications

Sabina Schmitt-Grohé

1 joint publications

Stefan Zielen

1 joint publications

Carlos Zagoya

Frequent Collaborators

1 joint publications

Sabina Schmitt-Grohé

1 joint publications

Stefan Zielen

1 joint publications

Carlos Zagoya

Top Related Videos

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients

Published on : Oct 15, 2017

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis

Published on : Mar 09, 2018

Rapid Viscoelastic Characterization of Airway Mucus Using a Benchtop Rheometer

Rapid Viscoelastic Characterization of Airway Mucus Using a Benchtop Rheometer

Published on : Apr 21, 2022

See more related videos

Top Related Videos

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients

Published on : Oct 15, 2017

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis

Published on : Mar 09, 2018

Rapid Viscoelastic Characterization of Airway Mucus Using a Benchtop Rheometer

Rapid Viscoelastic Characterization of Airway Mucus Using a Benchtop Rheometer

Published on : Apr 21, 2022

See more related videos